Joint Care Brands Encounter Stiff Competition

While the supplement industry waits nervously to see whether the NIHfunded Glucosamin/chondroitin Arthritis Intervention Trial (GAIT) gets a better spin after publication in the New England Journal of Medicine than than it got when the abstract was presented in November (see sidebar), marketers of glucosamine/chondroitin and related joint-care supplements continue trying to position and market their products for growth in a crowded category. Mature and increasingly saturated and

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.